AlphaQuest LLC Sells 3,349 Shares of Phibro Animal Health Corporation $PAHC

AlphaQuest LLC reduced its holdings in Phibro Animal Health Corporation (NASDAQ:PAHC) by 48.5% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 3,563 shares of the company’s stock after selling 3,349 shares during the period. AlphaQuest LLC’s holdings in Phibro Animal Health were worth $76,000 as of its most recent SEC filing.

Other institutional investors also recently added to or reduced their stakes in the company. Man Group plc bought a new position in Phibro Animal Health in the 4th quarter worth approximately $501,000. GAMMA Investing LLC increased its position in Phibro Animal Health by 2,011.4% in the 1st quarter. GAMMA Investing LLC now owns 36,718 shares of the company’s stock worth $784,000 after buying an additional 34,979 shares during the period. LPL Financial LLC increased its position in Phibro Animal Health by 46.8% in the 1st quarter. LPL Financial LLC now owns 128,335 shares of the company’s stock worth $2,741,000 after buying an additional 40,889 shares during the period. Lazard Asset Management LLC increased its position in Phibro Animal Health by 2,739.7% in the 4th quarter. Lazard Asset Management LLC now owns 1,647 shares of the company’s stock worth $34,000 after buying an additional 1,589 shares during the period. Finally, Nuveen Asset Management LLC increased its position in Phibro Animal Health by 21.4% in the 4th quarter. Nuveen Asset Management LLC now owns 588,001 shares of the company’s stock worth $12,348,000 after buying an additional 103,618 shares during the period. 99.34% of the stock is owned by institutional investors.

Phibro Animal Health Price Performance

Shares of PAHC stock opened at $38.19 on Thursday. The stock’s fifty day simple moving average is $30.10 and its 200 day simple moving average is $24.71. The company has a debt-to-equity ratio of 2.46, a current ratio of 2.76 and a quick ratio of 1.23. The firm has a market cap of $1.55 billion, a price-to-earnings ratio of 32.36, a P/E/G ratio of 0.54 and a beta of 0.89. Phibro Animal Health Corporation has a one year low of $16.16 and a one year high of $38.83.

Phibro Animal Health (NASDAQ:PAHC) last announced its quarterly earnings results on Wednesday, August 27th. The company reported $0.57 EPS for the quarter, beating the consensus estimate of $0.52 by $0.05. The business had revenue of $378.70 million for the quarter, compared to analyst estimates of $362.24 million. Phibro Animal Health had a return on equity of 32.14% and a net margin of 3.73%. Phibro Animal Health has set its FY 2026 guidance at 2.520-2.700 EPS. On average, analysts expect that Phibro Animal Health Corporation will post 1.95 earnings per share for the current fiscal year.

Phibro Animal Health Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, September 24th. Investors of record on Wednesday, September 3rd will be paid a $0.12 dividend. The ex-dividend date of this dividend is Wednesday, September 3rd. This represents a $0.48 annualized dividend and a yield of 1.3%. Phibro Animal Health’s payout ratio is currently 40.68%.

Analyst Upgrades and Downgrades

PAHC has been the topic of several recent research reports. Zacks Research lowered Phibro Animal Health from a “strong-buy” rating to a “hold” rating in a report on Thursday, August 28th. Wall Street Zen raised Phibro Animal Health from a “hold” rating to a “buy” rating in a report on Friday, May 9th. Morgan Stanley set a $34.00 price objective on Phibro Animal Health in a report on Thursday, August 28th. Bank of America lifted their price objective on Phibro Animal Health from $19.00 to $27.00 and gave the stock an “underperform” rating in a report on Friday, August 29th. Finally, JPMorgan Chase & Co. raised Phibro Animal Health from a “neutral” rating to an “overweight” rating and lifted their price objective for the stock from $25.00 to $35.00 in a report on Monday, July 7th. One equities research analyst has rated the stock with a Buy rating, four have assigned a Hold rating and two have issued a Sell rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Reduce” and a consensus target price of $28.40.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.